COMPLETED

Acute Effects of Cannabis on Everyday Life Memory

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine the acute effects of cannabis on various aspects of memory. Eligible participants will complete a drug screen. Participants who pass the drug screen will be asked to wear an Empatica E4 wristband for the duration of the study. Participants will provide a saliva sample from which cortisol will be extracted. They will then complete baseline measures of cannabis consumption patterns, level of intoxication, mood, anxiety, stress, and verbal intelligence. Next, participants will be randomly assigned to inhale vapor from cannabis containing 20mg THC, 40mg THC, or placebo; both cannabis and placebo will be obtained from the National Institute on Drug Abuse (NIDA). Participants will then will complete a battery of memory tests including tests of prospective, verbal, visuospatial, source, verbal working, visuospatial working, false, and temporal order memory. Memory tests will be completed across two blocks in a counterbalanced order. Saliva samples will be obtained two additional times after drug/placebo administration. Ratings of intoxication, mood, anxiety, and stress will be obtained three additional times after drug/placebo administration. The investigators hypothesize that participants who are randomly assigned to inhale cannabis vapor will perform worse on all memory tests than participants who inhale the placebo.

Official Title

Acute Effects of Cannabis on Everyday Life Memory

Quick Facts

Study Start:2023-08-21
Study Completion:2025-05-17
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05488509

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Have used cannabis at least once a week for at least one year
  2. * Willing to abstain from using any cannabis on the day of their scheduled testing session (minimum of 8 hours of abstinence)
  1. * Diagnosis of a serious psychiatric condition (psychosis, bipolar I, panic disorder)
  2. * Family history of psychosis
  3. * Diagnosis of a neurological disorder
  4. * Diagnosis of a chronic medical condition (e.g., heart disease, diabetes)
  5. * Diagnosis of a learning disability
  6. * History of multiple concussions
  7. * History of head injury that may impact cognition
  8. * Being pregnant
  9. * Lactating
  10. * History of adverse experiences with cannabis (anxiety, panic attacks)
  11. * Use of illicit drugs in the past 6 months
  12. * Heavy alcohol use (\>4 drinks, \>4 times/week)
  13. * Smoking/nicotine use
  14. * BMI greater than 34

Contacts and Locations

Principal Investigator

Ryan McLaughlin, PhD
PRINCIPAL_INVESTIGATOR
Washington State University
Carrie Cuttler
PRINCIPAL_INVESTIGATOR
Washington State University

Study Locations (Sites)

Washington State University
Pullman, Washington, 99163
United States

Collaborators and Investigators

Sponsor: Washington State University

  • Ryan McLaughlin, PhD, PRINCIPAL_INVESTIGATOR, Washington State University
  • Carrie Cuttler, PRINCIPAL_INVESTIGATOR, Washington State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-21
Study Completion Date2025-05-17

Study Record Updates

Study Start Date2023-08-21
Study Completion Date2025-05-17

Terms related to this study

Additional Relevant MeSH Terms

  • Cannabis Use